Trial Profile
Phase III study of peginterferon lambda-1a in patients with hepatitis C
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 26 Aug 2010
Price :
$35
*
At a glance
- Drugs Peginterferon lambda-1a (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors ZymoGenetics
- 25 Aug 2010 New trial record.